![CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma | Scientific Reports CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-017-17175-7/MediaObjects/41598_2017_17175_Fig1_HTML.jpg)
CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma | Scientific Reports
![Combined Evaluation of AFP, CA15-3, CA125, CA19-9, and CEA Tumor Markers in Patients with Hepatitis B and C | Semantic Scholar Combined Evaluation of AFP, CA15-3, CA125, CA19-9, and CEA Tumor Markers in Patients with Hepatitis B and C | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c1eae23e45b321ff3fb5ebd61780eb875db8cd89/5-Table1-1.png)
Combined Evaluation of AFP, CA15-3, CA125, CA19-9, and CEA Tumor Markers in Patients with Hepatitis B and C | Semantic Scholar
![Gene Variants That Affect Levels of Circulating Tumor Markers Increase Identification of Patients With Pancreatic Cancer - ScienceDirect Gene Variants That Affect Levels of Circulating Tumor Markers Increase Identification of Patients With Pancreatic Cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1542356519312388-gr1.jpg)
Gene Variants That Affect Levels of Circulating Tumor Markers Increase Identification of Patients With Pancreatic Cancer - ScienceDirect
![Evaluation of CEA, CA19-9, CRP and leucocyte count as prognostic marker... | Download Scientific Diagram Evaluation of CEA, CA19-9, CRP and leucocyte count as prognostic marker... | Download Scientific Diagram](https://www.researchgate.net/publication/321439366/figure/fig3/AS:959204714102785@1605703633412/Evaluation-of-CEA-CA19-9-CRP-and-leucocyte-count-as-prognostic-marker-for-CCA-patients.jpg)
Evaluation of CEA, CA19-9, CRP and leucocyte count as prognostic marker... | Download Scientific Diagram
![A genome wide association study of genetic loci that influence tumour biomarkers cancer antigen 19-9, carcinoembryonic antigen and α fetoprotein and their associations with cancer risk | Gut A genome wide association study of genetic loci that influence tumour biomarkers cancer antigen 19-9, carcinoembryonic antigen and α fetoprotein and their associations with cancer risk | Gut](https://gut.bmj.com/content/gutjnl/63/1/143/F1.large.jpg)
A genome wide association study of genetic loci that influence tumour biomarkers cancer antigen 19-9, carcinoembryonic antigen and α fetoprotein and their associations with cancer risk | Gut
![CEA, CA19-9, circulating DNA and circulating tumour cell kinetics in patients treated for metastatic colorectal cancer (mCRC) | British Journal of Cancer CEA, CA19-9, circulating DNA and circulating tumour cell kinetics in patients treated for metastatic colorectal cancer (mCRC) | British Journal of Cancer](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41416-021-01431-9/MediaObjects/41416_2021_1431_Fig1_HTML.png)
CEA, CA19-9, circulating DNA and circulating tumour cell kinetics in patients treated for metastatic colorectal cancer (mCRC) | British Journal of Cancer
![Change in CA 19-9 levels after chemoradiotherapy predicts survival in patients with locally advanced unresectable pancreatic cancer - Yang - Journal of Gastrointestinal Oncology Change in CA 19-9 levels after chemoradiotherapy predicts survival in patients with locally advanced unresectable pancreatic cancer - Yang - Journal of Gastrointestinal Oncology](https://cdn.amegroups.cn/journals/pbpc/files/journals/1/articles/1554/public/1554-PB5-R1.png/w300)
Change in CA 19-9 levels after chemoradiotherapy predicts survival in patients with locally advanced unresectable pancreatic cancer - Yang - Journal of Gastrointestinal Oncology
![Evaluating the efficacy of tumor markers CA 19-9 and CEA to predict operability and survival in pancreatic malignancies Evaluating the efficacy of tumor markers CA 19-9 and CEA to predict operability and survival in pancreatic malignancies](http://www.tropicalgastro.com/uploads/Untitlnkged-30.jpg)
Evaluating the efficacy of tumor markers CA 19-9 and CEA to predict operability and survival in pancreatic malignancies
![Evaluating the efficacy of tumor markers CA 19-9 and CEA to predict operability and survival in pancreatic malignancies Evaluating the efficacy of tumor markers CA 19-9 and CEA to predict operability and survival in pancreatic malignancies](http://www.tropicalgastro.com/uploads/Untitlemscd-31.jpg)